PreserVision AREDS Eye Vitamin & Mineral Supplement, Contains Vitamin C, A, E, Zinc & Copper, 90 Softgels (Packaging May Vary)

Price: $29.99 - $19.19
(as of May 18,2024 22:53:21 UTC – Details)

Bausch & Lomb PreserVision Soft Gels are based on the AREDS formula, an antioxidant vitamin and mineral supplement proven clinically effective in the Age-Related Eye Disease Study (AREDS). AREDS was a 10-year, independent study conducted by the National Eye Institute (NEI) of the National Institutes of Health (NIH). Bausch & Lomb PreserVision Soft Gels are based on the AREDS formula – a high potency anti-oxidant supplement with select vitamins and minerals, at levels that are well above those found in ordinary multivitamins and generally cannot be attained through diet alone. Now in convenient to take, 2 per day Soft Gels.
Is Discontinued By Manufacturer ‏ : ‎ No
Product Dimensions ‏ : ‎ 2.38 x 2.38 x 4 inches; 2.89 ounces
Item model number ‏ : ‎ AB53293
Date First Available ‏ : ‎ August 1, 2013
Manufacturer ‏ : ‎ Bausch & Lomb
ASIN ‏ : ‎ B00E7P6710
Country of Origin ‏ : ‎ USA

AGE RELATED EYE DISEASE AREDS SUPPLEMENT: PreserVision is the #1 doctor recommended eye vitamin to help reduce the risk of progression of moderate to advanced Age-related Macular Degeneration, and uses beta-carotene..
EYE VITAMINS FOR HEALTHY EYES: Bausch + Lomb carries a full line of ocular supplements with vitamins, minerals & nutrients that promote eye health, including Ocuvite eye vitamins for general eye health & PreserVision for age-related eye health concerns.
BAUSCH + LOMB EYE CARE EXPERTS: In 1853, John Jacob Bausch opened an optical goods store in Rochester, New York. Since then, Bausch + Lomb has continued to focus on innovation and quality in eye care products, from contact lenses to lubricant eye drops.
BAUSCH + LOMB EYE SUPPLEMENTS: Eye health is more than good vision and at Bausch + Lomb, we’re focused on all aspects of healthy eyes. Try our eye health vitamins and supplements if you’ve used other supplements based on the AREDS or AREDS2 study.